Estrogen, inflammation and cardiovascular risk in women: a critical appraisal

This publication has 100 references indexed in Scilit:

• Breast cancer and hormone-replacement therapy in the Million Women Study
  The Lancet, 2003
• Prospective Randomized Study of Effects of Unopposed Estrogen Replacement Therapy on Markers of Coagulation and Inflammation in Postmenopausal Women
  Journal of Clinical Endocrinology & Metabolism, 2001
• Effects of Estrogen Replacement on the Progression of Coronary-Artery Atherosclerosis
  New England Journal of Medicine, 2000
• Both Raloxifene and Estrogen Reduce Major Cardiovascular Risk Factors in Healthy Postmenopausal Women
  Arteriosclerosis, Thrombosis, and Vascular Biology, 1999
• Hormone replacement therapy and sensitive C-reactive protein concentrations in women with type-2 diabetes
  The Lancet, 1999
• Randomized Trial of Estrogen Plus Progestin for Secondary Prevention of Coronary Heart Disease in Postmenopausal Women
  JAMA, 1998
• The Long-Term Effects of Oral and Transdermal Postmenopausal Hormone Replacement Therapy on Nitric Oxide, Endothelin-1, Prostacyclin, and Thromboxane
  Fertility and Sterility, 1998
• Postmenopausal Estrogen and Progestin Use and the Risk of Cardiovascular Disease
  New England Journal of Medicine, 1996
• Vascular endothelium: An integrator of pathophysiologic stimuli in atherosclerosis
  The American Journal of Cardiology, 1995
• Estrogen replacement therapy and coronary heart disease: A quantitative assessment of the epidemiologic evidence
  Preventive Medicine, 1991